Immediate Impact
53 standout
Citing Papers
Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, 2019
2024 Standout
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
2024 Standout
Works of Kendall Beck being referenced
Real-World Experience With Tofacitinib Dose De-Escalation in Patients With Moderate and Severe Ulcerative Colitis
2023
Safety of dual biological therapy in Crohn’s disease: a case series of vedolizumab in combination with other biologics
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Kendall Beck | 119 | 114 | 27 | 72 | 31 | 364 | |
| Shan Yuan | 58 | 87 | 20 | 31 | 16 | 406 | |
| F.M. González-Roncero | 96 | 122 | 32 | 56 | 30 | 376 | |
| Koji Nanmoku | 133 | 66 | 45 | 32 | 39 | 391 | |
| J. A. Solís Herruzo | 131 | 125 | 37 | 88 | 47 | 388 | |
| Mary Eng | 183 | 78 | 22 | 84 | 20 | 388 | |
| M Turan | 107 | 95 | 17 | 96 | 42 | 354 | |
| J Wiggelinkhuizen | 79 | 108 | 4 | 64 | 30 | 371 | |
| Ramazan Danış | 71 | 56 | 21 | 28 | 39 | 313 | |
| A Keynan | 72 | 87 | 38 | 68 | 32 | 323 | |
| Anna Faura | 91 | 52 | 36 | 20 | 26 | 376 |
All Works
Login with ORCID to disown or claim papers
Loading papers...